Back to search
FDAFDA · Food and drugs·Recall number Z-0970-2024

Vortex Surgical ACTU8 FORCEPS, 25 GA, ADAPTIVE, REF VS0740.25

Published February 7, 2024 · Recall initiated: December 18, 2023

Summary

FDA records medical device Class II recall Z-0970-2024, published February 7, 2024 and initiated December 18, 2023. Recalling firm: Vortex Surgical Inc.; Status: Terminated; Reported quantity: 800 devices; Lot: UDI/DI 00810123481132, Lot Numbers 2212002 and 2212020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Reason for the voluntary recall is residue was identified on the two forceps tips of a customer in Korea. The residue is associated with one lot of forceps tips which were utilized in two lots of ACTU8 Adaptive Forceps Tips occurring in 0.25% of those lots.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Vortex Surgical Inc.
Distributor
Worldwide - US Nationwide distribution in the states of OH, WA, MN, MI, IA and the country of Republic of Korea
Lot
UDI/DI 00810123481132, Lot Numbers 2212002 and 2212020
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Vortex Surgical ACTU8 FORCEPS, 25 GA, ADAPTIVE, REF VS0740.25 recalled?

Yes. FDA published recall Z-0970-2024 on February 7, 2024. Reported hazard: Reason for the voluntary recall is residue was identified on the two forceps tips of a customer in Korea. The residue is associated with one lot of forceps tips which were utilized in two lots of ACTU8 Adaptive Forceps Tips occurring in 0.25% of those lots.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail